Home INDUSTRY news 23andMe’s Struggles Continue With HQ Downsized Amidst Declining Stock Price
INDUSTRY newsLife Science

23andMe’s Struggles Continue With HQ Downsized Amidst Declining Stock Price

Share
Share

South San Francisco-based genetics testing company 23andMe Holding Co. continues to grapple with financial difficulties, as evidenced by its decision to shrink its headquarters footprint by half. The company has listed 32,250 square feet for sublease at its Oyster Point Boulevard location. This move comes just two years after 23andMe relocated from a 155,000-square-foot in […]

Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.

Share

Partner Content

2026 Northern California CRE Rising Stars

NorCal rising stars 2026

Partner Content


Recent Posts

Related Articles

Morgan Stanley’s Prime Property Fund Puts 250,000 SQFT 150 California Street on the Market in San Francisco

Morgan Stanley's Prime Property Fund is marketing 150 California Street, a 249,960-square-foot,...

VTA Completes 83-Foot Tunnel Launch Shaft for $12.7B BART Silicon Valley Phase II, Readies Herrenknecht Boring Machine

The Santa Clara Valley Transportation Authority has finished the deep launch shaft...

Dermody Acquires Vacant 606,000 SQFT Tracy 205 Logistics Center from CBRE Investment Management Venture, Assessed at $70MM

Dermody has bought the Tracy 205 Logistics Center, a never-occupied 606,343-square-foot cross-dock...